Ryan Halsted

Stock Analyst at RBC Capital

(0.32)
# 4,436
Out of 5,242 analysts
15
Total ratings
22.22%
Success rate
-14.4%
Average return

Stocks Rated by Ryan Halsted

ICON Public Limited Company
May 18, 2026
Reinstates: Sector Perform
Price Target: $123
Current: $113.59
Upside: +8.28%
Medpace Holdings
Apr 24, 2026
Maintains: Outperform
Price Target: $522$484
Current: $415.19
Upside: +16.57%
Healthcare Services Group
Apr 23, 2026
Maintains: Sector Perform
Price Target: $22$24
Current: $21.04
Upside: +14.07%
Doximity
Mar 9, 2026
Reiterates: Outperform
Price Target: $44
Current: $19.75
Upside: +122.78%
IQVIA Holdings
Mar 3, 2026
Initiates: Outperform
Price Target: $221
Current: $167.27
Upside: +32.12%
Medline
Feb 26, 2026
Maintains: Outperform
Price Target: $47$53
Current: $36.42
Upside: +45.52%
Evolent Health
Feb 25, 2026
Maintains: Sector Perform
Price Target: $5$3
Current: $3.97
Upside: -24.43%
Privia Health Group
Jan 9, 2026
Reinstates: Outperform
Price Target: $31
Current: $23.33
Upside: +32.88%
TruBridge
Jan 9, 2026
Reinstates: Sector Perform
Price Target: $23
Current: $25.95
Upside: -11.35%
The Ensign Group
Apr 28, 2017
Downgrades: Underperform
Price Target: n/a
Current: $176.50
Upside: -